Diclofenac with or without an antiemetic for acute migraine headaches in adults
Author:
Affiliation:
1. Oxford Oxfordshire UK
2. Epsom and St Helier University Hospitals NHS Trust; Department of Respiratory Medicine; Wrythe Lane Carshalton London UK SM5 1AA
3. Plymouth UK
Publisher
Wiley
Subject
Pharmacology (medical)
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD008783.pub3/fullpdf
Reference61 articles.
1. Diclofenac-K (50 and 100mg) and placebo in the acute treatment of migraine;Dahlof;Cephalagia,1993
2. Efficacy and tolerability of diclofenac potassium sachets in migraine: a randomised, double-blind, cross-over study in comparison with diclofenac potassium tablets and placebo;Diener;Cephalagia,2006
3. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo;The Diclofenac-K/Sumatriptan Migraine Study Group;Cephalagia,1999
4. Efficacy and tolerability of a new powdered formulation of diclofenac potassium for oral solution for the acute treatment of migraine: results from the International Migraine Pain Assessment Clinical Trial (IMPACT);Lipton;Cephalagia,2010
5. Diclofenac epolamine is effective in the treatment of acute migraine attacks. A randomised, crossover, double blind, placebo-controlled, clinical study;Vecsei;Cephalagia,2007
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pharmacotherapies for Migraine and Translating Evidence From Bench to Bedside;Mayo Clinic Proceedings;2024-02
2. Non-CGRP Antagonist/Non-Triptan Options for Migraine Disease Treatment: Clinical Considerations;Current Pain and Headache Reports;2023-08-16
3. Revisiting Migraine: The Evolving Pathophysiology and the Expanding Management Armamentarium;Cureus;2023-02-02
4. Treating Vestibular Migraine When Pregnant and Postpartum: Progress, Challenges and Innovations;International Journal of Women's Health;2023-02
5. Polymorphisms of the Proinflammatory Cytokine Genes Modulate the Response to NSAIDs but Not to Triptans in Migraine Attacks;International Journal of Molecular Sciences;2022-12-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3